These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Control of disease tolerance to malaria by nitric oxide and carbon monoxide. Jeney V; Ramos S; Bergman ML; Bechmann I; Tischer J; Ferreira A; Oliveira-Marques V; Janse CJ; Rebelo S; Cardoso S; Soares MP Cell Rep; 2014 Jul; 8(1):126-36. PubMed ID: 24981859 [TBL] [Abstract][Full Text] [Related]
3. Lessons from sickle cell disease in the treatment and control of malaria. Rosenthal PJ N Engl J Med; 2011 Jun; 364(26):2549-51. PubMed ID: 21714653 [No Abstract] [Full Text] [Related]
4. A central role for free heme in the pathogenesis of severe malaria: the missing link? Ferreira A; Balla J; Jeney V; Balla G; Soares MP J Mol Med (Berl); 2008 Oct; 86(10):1097-111. PubMed ID: 18641963 [TBL] [Abstract][Full Text] [Related]
5. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Pamplona A; Ferreira A; Balla J; Jeney V; Balla G; Epiphanio S; Chora A; Rodrigues CD; Gregoire IP; Cunha-Rodrigues M; Portugal S; Soares MP; Mota MM Nat Med; 2007 Jun; 13(6):703-10. PubMed ID: 17496899 [TBL] [Abstract][Full Text] [Related]
6. The triumph of good over evil: protection by the sickle gene against malaria. Bunn HF Blood; 2013 Jan; 121(1):20-5. PubMed ID: 23118217 [TBL] [Abstract][Full Text] [Related]
7. Renal control of disease tolerance to malaria. Ramos S; Carlos AR; Sundaram B; Jeney V; Ribeiro A; Gozzelino R; Bank C; Gjini E; Braza F; Martins R; Ademolue TW; Blankenhaus B; Gouveia Z; Faísca P; Trujillo D; Cardoso S; Rebelo S; Del Barrio L; Zarjou A; Bolisetty S; Agarwal A; Soares MP Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5681-5686. PubMed ID: 30833408 [TBL] [Abstract][Full Text] [Related]
8. MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice. Belcher JD; Young M; Chen C; Nguyen J; Burhop K; Tran P; Vercellotti GM Blood; 2013 Oct; 122(15):2757-64. PubMed ID: 23908468 [TBL] [Abstract][Full Text] [Related]
9. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA. Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878 [TBL] [Abstract][Full Text] [Related]
17. Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice. Liu Y; Chen Y; Li Z; Han Y; Sun Y; Wang Q; Liu B; Su Z Eur J Immunol; 2013 Nov; 43(11):2907-18. PubMed ID: 23893352 [TBL] [Abstract][Full Text] [Related]
18. Heme dampens T-cell sequestration by modulating glial cell responses during rodent cerebral malaria. Dalko E; Genete D; Auger F; Dovergne C; Lambert C; Herbert F; Cazenave PA; Roland J; Pied S Brain Behav Immun; 2016 Nov; 58():280-290. PubMed ID: 27477919 [TBL] [Abstract][Full Text] [Related]
19. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis. Nie CQ; Bernard NJ; Schofield L; Hansen DS Infect Immun; 2007 May; 75(5):2275-82. PubMed ID: 17325053 [TBL] [Abstract][Full Text] [Related]